Spinal cord injury target-immunotherapy with TNF-α autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR/Cas9 plasmid
Baocheng Wang(Hong Kong University of Science and Technology), Guodong Sun(Zhejiang Entry-Exit Inspection and Quarantine Bureau), Jin Wo(First Affiliated Hospital of Jinan University), Shujie Tang(Guangzhou University of Chinese Medicine), Feng Zhang(Affiliated Hospital of North Sichuan Medical College), Hua Zhang(University of North Carolina at Chapel Hill), Zhizhong Li(Jinan University), Bowen Wu(Zhuzhou Central Hospital), Cheng Zhong(The University of Tokyo), Minmin Chang(Shandong University of Traditional Chinese Medicine), Shuxian Yang(First Affiliated Hospital of Jinan University), Renwen Zhang(Jinan University), Zhigang Zhou(Huzhou University)
Cited by 49
Related Papers
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
|The AAPS Journal|2012|583
Genetic evidence supports demic diffusion of Han culture
|Nature|2004|482
hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation
|Materials Science and Engineering C|2018|351
Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2
|Nature|2016|328
Bi-allelic DNAH8 Variants Lead to Multiple Morphological Abnormalities of the Sperm Flagella and Primary Male Infertility
|The American Journal of Human Genetics|2020|207